A look at 20 years of the dark side of biotech.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
31 March 2016
In the version of this article initially published, on p.286, in the timeline, far right, “2008 Intercept” should have read “2008 InterMune.” The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hodgson, J. When biotech goes bad. Nat Biotechnol 34, 284–291 (2016). https://doi.org/10.1038/nbt.3510
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3510
This article is cited by
-
Erratum: When biotech goes bad
Nature Biotechnology (2016)